Benzingaยท2025-10-08 12:33Group 1: Affirm Holdings, Inc. - Jim Cramer recommended buying Affirm Holdings, Inc. (NASDAQ:AFRM) after Rothschild & Co analyst Harry Bartlett upgraded the stock from Neutral to Buy and raised the price target from $74 to $101 [1][1] - Affirm shares rose 1% to settle at $76.65 on Tuesday [7] Group 2: Beam Therapeutics Inc. - Cramer expressed skepticism about Beam Therapeutics Inc. (NASDAQ:BEAM), stating "I can't go with" the stock [1] - Beam Therapeutics announced on Aug. 14 that the FDA granted regenerative medicine advanced therapy designation status for Beam-101 [1] - Beam shares declined 2.9% to settle at $25.13 on Tuesday [7] Group 3: Crown Castle Inc. - Cramer criticized the business model of Crown Castle Inc. (NYSE:CCI), calling it "not a sound one" [2] - RBC Capital analyst Jonathan Atkin upgraded Crown Castle from Sector Perform to Outperform but lowered the price target from $113 to $112 [2] - Crown Castle shares gained 1.2% to settle at $95.14 [7] Group 4: Shopify Inc. - Cramer stated that Shopify Inc. (NASDAQ:SHOP) is going "much higher," supported by TD Securities raising its price target from $130 to $156 [2] - Shopify shares fell 2% to close at $161.28 on Tuesday [7] Group 5: CoreWeave, Inc. - Cramer described CoreWeave, Inc. (NASDAQ:CRWV) as "good" [2] - CoreWeave announced plans to acquire Monolith AI, a UK-based pioneer in applying machine learning to complex physics and engineering problems [2] - CoreWeave shares fell 3.8% to settle at $128.83 [7] Group 6: CrowdStrike Holdings, Inc. - Cramer expressed confidence in CrowdStrike Holdings, Inc. (NASDAQ:CRWD) and its CEO George Kurtz, expecting the stock to rise [3] - Wells Fargo analyst Andrew Nowinski maintained an Overweight rating on CrowdStrike and raised the price target from $550 to $600 [3] - CrowdStrike shares fell 2.3% to close at $484.62 [7]